Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Key facts

Copied from the official Grants.gov record. Last verified October 30, 2026.

Program name

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Issuing agency

Centers for Disease Control - NCHHSTP (Department of Health and Human Services)

Opportunity number

CDC-RFA-PS-27-0239

Funding type

Cooperative Agreement

Funding purpose

Health

Status

Forecasted

Application deadline

Forecasted · estimated close May 24, 2027 (agency estimate)Agency note: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Agency estimates

Estimated posting: March 24, 2027. Estimated award date: August 30, 2027. Estimates can change.

Published award range

Not published by the agency

Estimated total program funding

$82,500,000

Expected number of awards

2

Cost sharing or match required

No

Eligible applicants (official categories)

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities/Indian housing authorities
• Native American tribal organizations (other than Federally recognized tribal governments)
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Private institutions of higher education
• For profit organizations other than small businesses
• Small businesses
• Unrestricted (open to any type of entity, subject to any clarification in Additional Information on Eligibility)

Relevant to

Businesses and NonprofitsHow we determined this: Grants.gov lists eligibility as Unrestricted. Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.

Geographic restrictions

None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.

Assistance Listing (CFDA)

93.488

Official source

View on Grants.gov ↗

Application URL

www.grants.gov/search-results-detail/363310 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.

Source identifier

Grants.gov opportunity ID 363310 · Funding opportunity number CDC-RFA-PS-27-0239

Posted

July 24, 2026 · Source last updated July 24, 2026

Last verified

October 30, 2026 (against Grants.gov)

Data completeness

83% of key fields published by the sourceNot published: published funding range, eligibility criteria text.

Record confidence

mediumforecast — dates and amounts are agency estimates.

Description (from the official listing)

This NOFO aims to strengthen services to prevent the infectious disease consequences of drug use in high impact settings serving people who use drugs (PWUD) through two components. Component 1 will improve service data by conducting a biennial survey of high-impact settings that serve PWUD to document capacity, needs, access, and service gaps. It will also improve timely local data on infectious disease consequences of drug use and the use of infectious disease testing, treatment, and prevention services at high-impact settings through a biennial biobehavioral survey of PWUD. Component 2 will increase support the availability and use of infectious disease testing, treatment and prevention services in high-impact settings serving PWUD. Applicants may apply for Component 1, Component 2, or both. Expected outcomes include enhanced capacity nationally and locally to use data to improve infectious disease testing, treatment and prevention services among PWUD, increased PWUD testing for HBV, HCV, and HIV, increased PWUD with hepatitis C who initiated treatment, and increased PWUD with HIV who engaged in care and treatment. This NOFO is in alignment with CDC priorities.

Agency contact

Monica Adams
ydy7@cdc.gov